Onco-Innovations Limited (CVE:ONCO)

COMMUNIQUÉ DE PRESSE

publié le 18/04/2026 à 01:00, il y a 21 jours 3 heures

Onco-Innovations Strengthens Executive Leadership with Appointment of Dr. Islam Mohamed as Chief Medical Officer and Stephen M. Novak as Chief of Research and Development
Onco-Innovations appoints Dr. Islam Mohamed as CMO and Stephen M. Novak as Chief of R&D, aiming to enhance clinical and development capabilities for advancing ONC010. Strategic leadership additions for Onco's transition to clinical-stage execution

Appointment Clinical Development R&D Onco-Innovations ONC010
BRÈVE

publiée le 08/04/2026 à 00:05, il y a 1 mois 1 jour

Onco-Innovations s'étend en Australie avec une nouvelle filiale et un partenariat

Essais Cliniques Recherche En Oncologie Stratégie Marketing Expansion Australienne Incitations À La R&D
BRÈVE

publiée le 08/04/2026 à 00:05, il y a 1 mois 1 jour

Onco-Innovations Expands into Australia with New Subsidiary and Partnership

Clinical Trials Marketing Strategy Oncology Research R&D Incentives Australian Expansion
COMMUNIQUÉ DE PRESSE

publié le 08/04/2026 à 00:00, il y a 1 mois 1 jour

Onco-Innovations Executes Engagement Agreement with RDI Partners and Establishes Onco-Innovations AU Pty. Ltd. to Advance Australian Phase I Strategy
Onco-Innovations announces engagement with RDI Partners & formation of ONCO AU subsidiary in Australia to support Phase I development activities & potential eligibility for Australia's R&D Tax Incentive program

Australia Onco-Innovations RDI Partners ONCO AU Phase I Development
BRÈVE

publiée le 12/03/2026 à 22:05, il y a 1 mois 27 jours

Onco-Innovations finalise un placement privé et lève 1,2 million de dollars

Placement Privé Financement De La Recherche Mandats Levée De Capitaux Onco-Innovations
BRÈVE

publiée le 12/03/2026 à 22:05, il y a 1 mois 27 jours

Onco-Innovations Completes Private Placement Raising $1.2 Million

Private Placement Warrants Capital Raising Research Funding Onco-Innovations
COMMUNIQUÉ DE PRESSE

publié le 12/03/2026 à 22:00, il y a 1 mois 27 jours

Onco-Innovations Announces Closing of Private Placement
Onco-Innovations Limited closes non-brokered private placement for $1,215,500, issuing 1,870,000 Units. Proceeds for corporate development and working capital. Securities subject to statutory hold period

Private Placement Securities Working Capital Cancer Research Onco-Innovations Limited
BRÈVE

publiée le 12/02/2026 à 15:05, il y a 2 mois 24 jours

Onco-Innovations ajuste ses tarifs pour les placements privés

Placement Privé Stratégie Financière Conformité Réglementaire Onco-Innovations Annonce D'investissement
BRÈVE

publiée le 12/02/2026 à 15:05, il y a 2 mois 24 jours

Onco-Innovations Adjusts Pricing for Private Placement

Private Placement Regulatory Compliance Financial Strategy Onco-Innovations Investment Announcement
COMMUNIQUÉ DE PRESSE

publié le 12/02/2026 à 15:00, il y a 2 mois 24 jours

Onco-Innovations Announces Amendment to Private Placement Pricing
Onco-Innovations Limited amends pricing for non-brokered private placement, offering 3,076,923 units at $0.65 each with warrants. Proceeds for corporate and working capital purposes

Private Placement Warrants Corporate Funding Onco-Innovations Limited Pricing Amendment

Publié le 07/05/2026 à 19:15, il y a 1 jour 9 heures

2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Publié le 07/05/2026 à 19:15, il y a 1 jour 9 heures

Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Publié le 07/05/2026 à 19:06, il y a 1 jour 9 heures

Disclosure of Share Capital and Voting Rights as of April 30, 2026
Publié le 07/05/2026 à 19:06, il y a 1 jour 9 heures

Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Publié le 07/05/2026 à 19:00, il y a 1 jour 9 heures

ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

Voir tout LES ECHOS COMFI WIRE

Publié le 09/05/2026 à 01:55, il y a 2 heures 32 minutes

Prospect Ridge Announces Board Resignation
Publié le 09/05/2026 à 01:40, il y a 2 heures 47 minutes

Findev Inc. Issues Corrective Disclosure
Publié le 09/05/2026 à 01:30, il y a 2 heures 57 minutes

Star Copper Announces Agreement with Zimtu Capital Corp.
Publié le 09/05/2026 à 00:00, il y a 4 heures 27 minutes

Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Publié le 08/05/2026 à 23:01, il y a 5 heures 26 minutes

Water Ways Announces Corporate Updates

Voir tout ACCESSWIRE

Publié le 08/05/2026 à 20:38, il y a 7 heures 49 minutes

EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Publié le 08/05/2026 à 19:12, il y a 9 heures 14 minutes

EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Publié le 08/05/2026 à 19:02, il y a 9 heures 25 minutes

Metall Zug – Annual General Meeting of Shareholders approves all proposals
Publié le 08/05/2026 à 18:29, il y a 9 heures 58 minutes

Designated Person Notification
Publié le 08/05/2026 à 18:29, il y a 9 heures 58 minutes

Designated Person Notification

Voir tout EQS

News